论文部分内容阅读
2012年两市上市公司首份年报于19日披露,化工股威远生化成为第一家披露年报业绩的上市公司。报告显示,2012年该公司实现营业收入18亿元,实现净利润4217万元,分别比上年同期增加1.49%、58%。威远生化主营业务分为农、兽药行业及能源化工行业。主营方面,公司在报告期内新增了草铵磷、
In 2012, the first annual report of listed companies in the two cities was disclosed on the 19th and chemical stock Weiyuan Biochemical became the first listed company to disclose annual results. The report shows that in 2012 the company achieved operating income of 1.8 billion yuan, net profit of 42.17 million yuan, respectively, an increase of 1.49%, 58% over the previous year. Weiyuan Biochemical main business is divided into agriculture, veterinary medicine industry and energy chemical industry. Main aspects of the company during the reporting period added glufosinate,